提奥芬辅助的细胞吸收增强,用于高效的NIR-II癌症光异常剂
Yue Zhang1, Jia Yu1, Chunbin Li1
1College of Chemistry and Chemical Engineering, Inner Mongolia Key Laboratory of Fine Organic Synthesis, Inner Mongolia University, Hohhot 010021, P. R. China. jiangguoyu@mail.ipc.ac.cn.
概括
研究人员用烯开发了新的近红外II (NIR-II) 光声学剂 (PTAs). 这些PTA增强细胞吸收,并使精确的NIR-II成像导向光动力学和光热癌症治疗成为可能.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 光动力疗法 (PDT) 和光热疗法 (PTT) 是有前途的癌症治疗方法.
- 近红外II (NIR-II) 窗口为生物医学成像提供更深的组织透.
- 开发用于联合成像和治疗的有效药物至关重要.
研究的目的:
- 设计和合成用于癌症治疗的新型NIR-II光声学剂 (PTA).
- 为了研究蒂奥芬结合对光物理性质和细胞吸收的影响.
- 评估这些PTA在NIR-II成像指导PDT和PTT中的有效性.
主要方法:
- 合成两个系列的PTAs与捐赠者-接受者 (D-A) 或捐赠者-接受者-捐赠者 (D-A-D) 的结构.
- 将蒂奥芬单元纳入PTA骨干. 在PTA骨干中.
- 光物理性质的表征,包括在NIR-II区域的辐射.
- 评估癌细胞中细胞吸收的情况.
- 在体外和体内评估NIR-II成像指导的PDT/PTT疗效.
主要成果:
- 设计的PTA在NIR-II区域显示出排放,原因是添加了烯.
- 与对照组相比,含有蒂奥芬的PTA显示细胞吸收增强.
- 取得了成功的NIR-II成像.
- 在由NIR-II成像指导的联合PDT/PTT癌症光疗中已证明有效性.
结论:
- 基于蒂奥芬的PTA在NIR-II成像和癌症光疗中有效.
- 这些PTA可以改善细胞吸收和治疗结果.
- 开发的药物有可能对晚期癌症产生治疗.
相关概念视频
Nuclear Overhauser Enhancement (NOE)
Irradiation of a spin-active nucleus causes an increase or decrease in the signal intensity of neighboring nuclei that are not necessarily chemically bonded or involved in J-coupling. This phenomenon, called the nuclear Overhauser enhancement (NOE), results from through-space interactions between the nuclear spins. The NOE effect decreases with increasing internuclear distance and is generally not observed beyond 4 angstroms. In NOE, dipole-dipole interactions between neighboring spin-active...
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)
Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) is an advanced Nuclear Magnetic Resonance (NMR) technique specifically designed to detect and enhance the signals of low-abundance nuclei, such as carbon-13 and nitrogen-15, in small molecules. The fundamental principle behind INEPT is the transfer of polarization from a more abundant and highly polarizable nucleus, typically hydrogen-1, to the low-abundance nucleus of interest. This process effectively boosts the NMR signal of the...


